Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L5WI
|
|||
Former ID |
DNC009840
|
|||
Drug Name |
N-hydroxy-8-(naphthalen-2-yl)octanamide
|
|||
Synonyms |
CHEMBL95747; N-hydroxy-8-(naphthalen-2-yl)octanamide; SCHEMBL3378763; KWFDCRKEDDNSLQ-UHFFFAOYSA-N; N-Hydroxy-8-(2-naphthyl)octanamide; BDBM50114833; ZINC13474419; 8-Naphthalen-2-yl-octanoic acid hydroxyamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H23NO2
|
|||
Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)CCCCCCCC(=O)NO
|
|||
InChI |
1S/C18H23NO2/c20-18(19-21)11-5-3-1-2-4-8-15-12-13-16-9-6-7-10-17(16)14-15/h6-7,9-10,12-14,21H,1-5,8,11H2,(H,19,20)
|
|||
InChIKey |
KWFDCRKEDDNSLQ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Eur J Med Chem. 2009 Jul;44(7):2868-76. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.